german-peptides The GFLG peptide, a short sequence of amino acids (Gly-Phe-Leu-Gly), has emerged as a critical element in advanced biomedical research, particularly in the realm of targeted drug delivery and the development of responsive biomaterials2008年3月17日—Here, we used phage display to identify a novelpeptide(SP94), which binds specifically to hepatocellular carcinoma cells.. Its unique characteristic lies in its susceptibility to cleavage by specific enzymes, most notably cathepsin B, a protease frequently upregulated in the tumor microenvironment and within cellular lysosomes. This enzymatic sensitivity makes the GFLG peptide an ideal "smart" linker, enabling the controlled release of therapeutic payloads or the activation of biomaterial functions precisely where and when they are needed.作者：PE Saw·2019·被引用次数：283—Phage display technique allows high affinity target-bindingpeptidesto be selected from a complex mixture pool of billions of displayedpeptideson phage. The effectiveness of GFLG peptide linkers in enhancing drug accumulation, improving therapeutic efficacy, and minimizing off-target toxicity is a subject of extensive investigation across numerous scientific studies.
Cathepsin B is a lysosomal cysteine protease that plays a significant role in intracellular protein degradation.Synthesis scheme and 1 H NMR spectra of MePEG-GFLG ... However, its elevated expression in various pathological conditions, including cancer, makes it a valuable target for enzyme-responsive drug delivery systems. The GFLG peptide sequence is specifically designed to be recognized and cleaved by cathepsin B. When incorporated as a linker between a therapeutic agent (like a drug or protein) and a carrier molecule (such as a polymer, nanoparticle, or antibody), the GFLG sequence remains intact during circulation in the bloodstream. Upon internalization into cells where cathepsin B levels are high, the GFLG linker is efficiently cleaved, releasing the active therapeutic agent. This mechanism ensures that the drug is primarily delivered to its intended site of action, thereby increasing its concentration at the target and reducing systemic side effects.
Studies have explored the use of GFLG peptide linkers in various drug conjugate designs作者：J Wang·2020·被引用次数：35—mPEGylated dendron–GFLG–DOX conjugate based nanoparticlescould significantly promote cellular uptake and accumulation, potent cytotoxicity and apoptosis .... For instance, conjugates incorporating GFLG have been shown to improve the stability of drug delivery systems while facilitating the targeted release of cytotoxic drugs like doxorubicin (DOX) within cancer cellsDesign and evaluation of dual-functional aptamer-peptide .... The precise cleavage kinetics and enzymatic susceptibility of the GFLG peptide contribute to the controlled release profile, allowing for a sustained therapeutic effect作者：Z Li·2025·被引用次数：21—In vivo studies demonstrated that MA PDCs repolarized GAMs, boosted immune response, and resensitized chemotherapeutic toxicity, offering a much-improved anti- .... Furthermore, variations like GGFG are also designed for rapid toxin release, highlighting the adaptability of peptide linkers for different therapeutic strategies.
The utility of the GFLG peptide extends beyond traditional drug delivery作者：X Jin·2020·被引用次数：48—The protease specifically hydrolyzes peptides such as Leu-Leu, Arg-Arg, Ala-Leu, Phe-Arg, Phe-Lys, Gly-Phe-Leu-Gly, Ala-Leu-Ala-Leu, etc.Gly-Phe-Leu-Gly (GFLG) .... Its ability to respond to specific enzymatic activity makes it valuable in the design of smart biomaterials and diagnostic tools. For example, GFLG-based linkers can be integrated into hydrogels or scaffolds that degrade or release signaling molecules in response to cathepsin B.作者：P Zhang·2013·被引用次数：137—This GFLG tetrapeptide has been widely used as a linker in the developmentofpolymer-drug conjugates, and is sensitive towards the lysosomal enzyme, cathepsin ... This could be crucial for tissue engineering applications, where controlled release of growth factors or extracellular matrix components is desired to promote healing and regenerationCN102127154A - A54-gflg-dox偶联物及其偶联方法和应用.
In diagnostics, GFLG peptides can be employed in systems designed to detect cathepsin B activity.Chlorin e6-Conjugated and PEGylated Immune Checkpoint ... By conjugating a detectable signal (eCN102127154A - A54-gflg-dox偶联物及其偶联方法和应用.g., a fluorescent probe) to a molecule that is released upon GFLG cleavage, researchers can develop assays that indicate the presence of elevated cathepsin B levels, a potential biomarker for disease progression or treatment response. The development of mPEGylated dendron–GFLG–DOX conjugate based nanoparticles exemplifies this multidisciplinary approach, combining drug delivery with potential diagnostic capabilities.
While the GFLG peptide offers significant advantages, several factors are critical for its successful implementationComparative Enzymatic and Stability Assays Reveal GPLG as .... The metabolic stability of the linker and the overall conjugate is paramount to ensure sufficient circulation time and effective delivery. Researchers often employ modifications, such as PEGylation (e.作者：L Pethő·2020·被引用次数：18—The GFLG spacer is a well-known and widely used cathepsin B labileshortpeptide sequence, which enables the lysosomal metabolism of the ...g., using MePEG–GFLG peptide), to enhance the stability and pharmacokinetics of the GFLG-containing constructsDesign, synthesis and bioactivity evaluation of novel fusion .... The choice of the carrier molecule and the conjugation strategy also plays a vital role in the overall performance of the system.作者：YIL Jeong·2019·被引用次数：9—ICI Nanocomposites.MePEG–GFLG peptide(216 mg) in 10 mL of DMSO was mixed with 3.8 mg of EDAC and 2.3 mg of NHS to make NHS ...
Comparing different peptide sequences, such as GFLG and GPLG, is an ongoing area of research to optimize cleavage efficiency and specificity. The GFLG (Gly-Phe-Leu-Gly) sequence, as a specific substrate for cathepsin B, offers a well-characterized cleavage mechanism.作者：Z Li·2025·被引用次数：21—In vivo studies demonstrated that MA PDCs repolarized GAMs, boosted immune response, and resensitized chemotherapeutic toxicity, offering a much-improved anti- ... However, understanding the subtle differences in enzymatic recognition and cleavage rates for related sequences is essential for fine-tuning therapeutic outcomes作者：VS Egorova·2023·被引用次数：28—The GFLG peptideincreased the stability of the systemand after AuNR–LAX internalization into cancer cells, CtsB-mediated cleavage induced DOX ....
In conclusion, the GFLG peptide represents a sophisticated tool in modern biomedical science2014年4月6日—The drug DOX is conjugated to the periphery of dendrimer via an enzyme-responsive tetra-peptidelinker Gly-Phe-Leu-Gly (GFLG). The dendrimer–DOX .... Its ability to act as an enzyme-responsive linker, particularly for cathepsin B, underpins its widespread application in targeted drug delivery, enabling more effective and safer cancer therapies. As research continues to advance, the GFLG peptide and similar enzyme-cleavable sequences are poised to play an increasingly significant role in the development of next-generation therapeutics and advanced biomaterials.
Join the newsletter to receive news, updates, new products and freebies in your inbox.